Inovação em saúde: uma análise da parceria de desenvolvimento de novos produtos farmacêuticos entre UNICAMP e DNDi.

Abstract

This dissertation analyses a partnership between DNDi and UNICAMP to develop new pharmaceutical entities to treat neglected diseases. The partnership is contextualized into different strategies to build industrial and innovative capacities like the ones implemented by the United Kingdom when industrializing and the United states of America protectionists policies. It is also discussed how the role of the public sector, so present on catch-up strategies of developed countries, is diminished by the dominant narrative of how innovation fundamentally happens on the private sector. The discussion also passes through the evolution of commercial agreements that enhance protection of intellectual property, along with the emergency of AIDS epidemic and the consequences of the access to medicines campaigns. The partnership is presented as an alternative to the connection of academic research to profitability, promoting connections between the involved parts that differ from the the traditional relationship between university and private partner. To do such analysis the dissertation is based on documental and bibliographical searches, along with informative interviews with the parts involved on the partnership (DNDi and UNICAMP).